This article is a correction to:
Nocebo effects in systemic therapies for adult plaque psoriasis: A systematic review and meta-analysis
Bryan Ma
Ye-Jean Park1,2
P. Régine Mydlarski- 1Division of Dermatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
- 2Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
A corrigendum on
Nocebo effects in systemic therapies for adult plaque psoriasis: a systematic review and meta-analysis
by Ma, B., Park, Y.-J., Barber, K., and Mydlarski, P. R. (2024). Front. Med. 11:1373520. doi: 10.3389/fmed.2024.1373520
In the published article, there was an error in Table 1 as published. In the row “Any AE” under the columns “Non-biologic” and “Non-biologic Placebo,” the numbers entered of 57.10 (54.66 – 59.52) and 49.78 (47.12 – 52.44), respectively, are an accidental transposition of these same numbers from the “Intervention Pooled” and “Placebo Pooled” columns. Instead, the numbers under row “Any AE” for column “Non-biologic” should be 63.02 (56.80 – 69.03) and for column “Non-biologic Placebo” should be 48.75 (41.02 – 56.51). The corrected Table 1 appears below.
Table 1
Table 1. Pooled proportion of patients experiencing adverse events and risk difference between systemic therapy and placebo stratified by treatment class.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: psoriasis, systemic therapy, nocebo effect, randomized controlled trial, biologic
Citation: Ma B, Park Y-J, Barber K and Mydlarski PR (2024) Corrigendum: Nocebo effects in systemic therapies for adult plaque psoriasis: a systematic review and meta-analysis. Front. Med. 11:1439345. doi: 10.3389/fmed.2024.1439345
Received: 27 May 2024; Accepted: 18 June 2024;
Published: 27 June 2024.
Edited and reviewed by: Robert Gniadecki, University of Alberta, Canada
Copyright © 2024 Ma, Park, Barber and Mydlarski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: P. Régine Mydlarski, rmydlars@ucalgary.ca